Trajan Group Holdings Limited (ASX:TRJ)

Stephen Tomisich
CEO & MD
Market Cap (AUD): 421.05M
Sector: Health Care
Last Trade (AUD): 3.25 +0 (+0%)
Tab Bar

1. About

Trajan Group Holdings Limited (ASX:TRJ) is a developer and manufacturer of analytical and life sciences products and devices.

Through Trajan's portfolio and technology pipeline the Group is supporting the move towards decentralised, personalised data-based healthcare. Trajan operates through two divisions:

Analytics

Trajan is a global provider of engineered components and analytical technologies with a background in chromatography and mass spectrometry. These technologies enable measurements in biology, food and the environment.

Trajan is a key partner in producing critical components and materials for analytical workflow and measurement. The Group's aim is to design and deliver a portfolio of analytical tools to deliver best practice laboratory performance, enhancing confidence in results.

Life Sciences

Trajan's life science solutions span the development of medical devices for microsample collection, premium pathology products, precision components for mass spectrometry and automated workflow solutions.

Trajan seeks to enhance and optimise workflows with a variety of automated preparative or sample collection systems for laboratories, or can generate custom solutions for life science research and development.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk